Position in VRTX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,725,475
+$778,311 QoQ
Shares Held
7,500
+13.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.17%
of 13F equity value
Holder Rank
#537
of 1,735 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Graphene Investments SAS holds $7,195,443 across 2 Biotechnology names. VRTX ranks #1 (51.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
7,500 | $3,725,475 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
14,400 | $3,469,968 |
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,725,475 | 7,500 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,947,164 | 6,600 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,400,200 | 7,500 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $3,250,612 | 8,300 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $3,027,360 | 6,800 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,666,510 | 5,500 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,617,550 | 6,500 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $3,302,068 | 7,100 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,327,912 | 7,100 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $3,427,682 | 8,200 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,336,498 | 8,200 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $3,129,660 | 9,000 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,167,190 | 9,000 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,213,714 | 10,200 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,772,288 | 9,600 | Shares | Sole | 2023-02-21 | |
| No filing history on record for this holder in this stock. | ||||||